Health-Related Quality of Life (HRQL) in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC) Treated with Cemiplimab: Post Hoc Exploratory Analysis of a Phase 2 Clinical Trial. J of Skin [Internet]. 2020 Oct. 27 [cited 2025 Apr. 19];4(6):s122. Available from: https://skin.dermsquared.com/skin/article/view/1095